Lung cancer is the most common cause of cancer death in the United States.
1 The National Lung Screening Trial (NLST) demonstrated a 20% reduction in lung cancer mortality with 3 rounds of low-dose computed tomography (CT) screening as compared with chest radiography, over a mean follow-up of 6.4 years.
2 Consequently, the US Preventive Services Task Force (USPSTF) and the US Centers for Medicare & Medicaid Services now recommend annual CT screening for a risk factor–based subgroup of smokers—current and former smokers aged 55 to 80 years and 55 to 77 years, respectively, with at least 30 pack-years of smoking and, for former smokers, no more than 15 years since quitting.
3,4 These were largely based on the entry criteria for the NLST as well as microsimulation models that considered subgroups defined by age, pack-year, and quit-year criteria.
5,6